Artificial Intelligence In Genomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510243230

Publication Date:

October 28, 2024

Pages:

127

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Artificial intelligence is massively utilized in genomics for developing & exploring novel medicines for curing rare ailments. Moreover, it makes use of various DNA sequencing procedures, bioinformatics, and recombinant DNAs for assembling, sequencing, analyzing, and functioning of genomes.
The global market for Artificial Intelligence In Genomics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate 鈧�9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.68%, including software, hardware and services.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence In Genomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Intelligence In Genomics by region & country, by Type, and by Application.
The Artificial Intelligence In Genomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence In Genomics.
Market Segmentation
By Company
Deep Genomics
IBM
FDNA Inc.
Microsoft
Genoox Ltd.
NVIDIA Corporation
Lifebit
BenevolentAI
Cambridge Cancer Genomics
Fabric Genomics Inc.
Verge Genomics
SOPHiA GENETICS
Freenome Holdings, Inc.
MolecularMatch Inc.
Data4Cure Inc.
PrecisionLife Ltd
Diploid
DNAnexus Inc.
Segment by Type:
Machine Learning
Computer Vision
Segment by Application
Pharma
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Intelligence In Genomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Artificial Intelligence In Genomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Artificial Intelligence In Genomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Artificial Intelligence In Genomics Product Introduction
1.2 Global Artificial Intelligence In Genomics Market Size Forecast
1.3 Artificial Intelligence In Genomics Market Trends & Drivers
1.3.1 Artificial Intelligence In Genomics Industry Trends
1.3.2 Artificial Intelligence In Genomics Market Drivers & Opportunity
1.3.3 Artificial Intelligence In Genomics Market Challenges
1.3.4 Artificial Intelligence In Genomics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence In Genomics Players Revenue Ranking (2023)
2.2 Global Artificial Intelligence In Genomics Revenue by Company (2019-2024)
2.3 Key Companies Artificial Intelligence In Genomics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Intelligence In Genomics Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence In Genomics
2.6 Artificial Intelligence In Genomics Market Competitive Analysis
2.6.1 Artificial Intelligence In Genomics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence In Genomics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence In Genomics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Machine Learning
3.1.2 Computer Vision
3.2 Global Artificial Intelligence In Genomics Sales Value by Type
3.2.1 Global Artificial Intelligence In Genomics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Intelligence In Genomics Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Intelligence In Genomics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma
4.1.2 Research
4.2 Global Artificial Intelligence In Genomics Sales Value by Application
4.2.1 Global Artificial Intelligence In Genomics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Intelligence In Genomics Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Intelligence In Genomics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Intelligence In Genomics Sales Value by Region
5.1.1 Global Artificial Intelligence In Genomics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Intelligence In Genomics Sales Value by Region (2019-2024)
5.1.3 Global Artificial Intelligence In Genomics Sales Value by Region (2025-2030)
5.1.4 Global Artificial Intelligence In Genomics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Artificial Intelligence In Genomics Sales Value, 2019-2030
5.2.2 North America Artificial Intelligence In Genomics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Artificial Intelligence In Genomics Sales Value, 2019-2030
5.3.2 Europe Artificial Intelligence In Genomics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence In Genomics Sales Value, 2019-2030
5.4.2 Asia Pacific Artificial Intelligence In Genomics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Artificial Intelligence In Genomics Sales Value, 2019-2030
5.5.2 South America Artificial Intelligence In Genomics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence In Genomics Sales Value, 2019-2030
5.6.2 Middle East & Africa Artificial Intelligence In Genomics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence In Genomics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Intelligence In Genomics Sales Value
6.3 United States
6.3.1 United States Artificial Intelligence In Genomics Sales Value, 2019-2030
6.3.2 United States Artificial Intelligence In Genomics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Intelligence In Genomics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Intelligence In Genomics Sales Value, 2019-2030
6.4.2 Europe Artificial Intelligence In Genomics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Intelligence In Genomics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Intelligence In Genomics Sales Value, 2019-2030
6.5.2 China Artificial Intelligence In Genomics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Intelligence In Genomics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Intelligence In Genomics Sales Value, 2019-2030
6.6.2 Japan Artificial Intelligence In Genomics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Intelligence In Genomics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Intelligence In Genomics Sales Value, 2019-2030
6.7.2 South Korea Artificial Intelligence In Genomics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Intelligence In Genomics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence In Genomics Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Intelligence In Genomics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Intelligence In Genomics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Intelligence In Genomics Sales Value, 2019-2030
6.9.2 India Artificial Intelligence In Genomics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Intelligence In Genomics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Deep Genomics
7.1.1 Deep Genomics Profile
7.1.2 Deep Genomics Main Business
7.1.3 Deep Genomics Artificial Intelligence In Genomics Products, Services and Solutions
7.1.4 Deep Genomics Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.1.5 Deep Genomics Recent Developments
7.2 IBM
7.2.1 IBM Profile
7.2.2 IBM Main Business
7.2.3 IBM Artificial Intelligence In Genomics Products, Services and Solutions
7.2.4 IBM Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.2.5 IBM Recent Developments
7.3 FDNA Inc.
7.3.1 FDNA Inc. Profile
7.3.2 FDNA Inc. Main Business
7.3.3 FDNA Inc. Artificial Intelligence In Genomics Products, Services and Solutions
7.3.4 FDNA Inc. Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.3.5 Microsoft Recent Developments
7.4 Microsoft
7.4.1 Microsoft Profile
7.4.2 Microsoft Main Business
7.4.3 Microsoft Artificial Intelligence In Genomics Products, Services and Solutions
7.4.4 Microsoft Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.4.5 Microsoft Recent Developments
7.5 Genoox Ltd.
7.5.1 Genoox Ltd. Profile
7.5.2 Genoox Ltd. Main Business
7.5.3 Genoox Ltd. Artificial Intelligence In Genomics Products, Services and Solutions
7.5.4 Genoox Ltd. Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.5.5 Genoox Ltd. Recent Developments
7.6 NVIDIA Corporation
7.6.1 NVIDIA Corporation Profile
7.6.2 NVIDIA Corporation Main Business
7.6.3 NVIDIA Corporation Artificial Intelligence In Genomics Products, Services and Solutions
7.6.4 NVIDIA Corporation Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.6.5 NVIDIA Corporation Recent Developments
7.7 Lifebit
7.7.1 Lifebit Profile
7.7.2 Lifebit Main Business
7.7.3 Lifebit Artificial Intelligence In Genomics Products, Services and Solutions
7.7.4 Lifebit Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.7.5 Lifebit Recent Developments
7.8 BenevolentAI
7.8.1 BenevolentAI Profile
7.8.2 BenevolentAI Main Business
7.8.3 BenevolentAI Artificial Intelligence In Genomics Products, Services and Solutions
7.8.4 BenevolentAI Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.8.5 BenevolentAI Recent Developments
7.9 Cambridge Cancer Genomics
7.9.1 Cambridge Cancer Genomics Profile
7.9.2 Cambridge Cancer Genomics Main Business
7.9.3 Cambridge Cancer Genomics Artificial Intelligence In Genomics Products, Services and Solutions
7.9.4 Cambridge Cancer Genomics Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.9.5 Cambridge Cancer Genomics Recent Developments
7.10 Fabric Genomics Inc.
7.10.1 Fabric Genomics Inc. Profile
7.10.2 Fabric Genomics Inc. Main Business
7.10.3 Fabric Genomics Inc. Artificial Intelligence In Genomics Products, Services and Solutions
7.10.4 Fabric Genomics Inc. Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.10.5 Fabric Genomics Inc. Recent Developments
7.11 Verge Genomics
7.11.1 Verge Genomics Profile
7.11.2 Verge Genomics Main Business
7.11.3 Verge Genomics Artificial Intelligence In Genomics Products, Services and Solutions
7.11.4 Verge Genomics Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.11.5 Verge Genomics Recent Developments
7.12 SOPHiA GENETICS
7.12.1 SOPHiA GENETICS Profile
7.12.2 SOPHiA GENETICS Main Business
7.12.3 SOPHiA GENETICS Artificial Intelligence In Genomics Products, Services and Solutions
7.12.4 SOPHiA GENETICS Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.12.5 SOPHiA GENETICS Recent Developments
7.13 Freenome Holdings, Inc.
7.13.1 Freenome Holdings, Inc. Profile
7.13.2 Freenome Holdings, Inc. Main Business
7.13.3 Freenome Holdings, Inc. Artificial Intelligence In Genomics Products, Services and Solutions
7.13.4 Freenome Holdings, Inc. Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.13.5 Freenome Holdings, Inc. Recent Developments
7.14 MolecularMatch Inc.
7.14.1 MolecularMatch Inc. Profile
7.14.2 MolecularMatch Inc. Main Business
7.14.3 MolecularMatch Inc. Artificial Intelligence In Genomics Products, Services and Solutions
7.14.4 MolecularMatch Inc. Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.14.5 MolecularMatch Inc. Recent Developments
7.15 Data4Cure Inc.
7.15.1 Data4Cure Inc. Profile
7.15.2 Data4Cure Inc. Main Business
7.15.3 Data4Cure Inc. Artificial Intelligence In Genomics Products, Services and Solutions
7.15.4 Data4Cure Inc. Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.15.5 Data4Cure Inc. Recent Developments
7.16 PrecisionLife Ltd
7.16.1 PrecisionLife Ltd Profile
7.16.2 PrecisionLife Ltd Main Business
7.16.3 PrecisionLife Ltd Artificial Intelligence In Genomics Products, Services and Solutions
7.16.4 PrecisionLife Ltd Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.16.5 PrecisionLife Ltd Recent Developments
7.17 Diploid
7.17.1 Diploid Profile
7.17.2 Diploid Main Business
7.17.3 Diploid Artificial Intelligence In Genomics Products, Services and Solutions
7.17.4 Diploid Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.17.5 Diploid Recent Developments
7.18 DNAnexus Inc.
7.18.1 DNAnexus Inc. Profile
7.18.2 DNAnexus Inc. Main Business
7.18.3 DNAnexus Inc. Artificial Intelligence In Genomics Products, Services and Solutions
7.18.4 DNAnexus Inc. Artificial Intelligence In Genomics Revenue (US$ Million) & (2019-2024)
7.18.5 DNAnexus Inc. Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence In Genomics Industrial Chain
8.2 Artificial Intelligence In Genomics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Intelligence In Genomics Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Intelligence In Genomics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Deep Genomics
IBM
FDNA Inc.
Microsoft
Genoox Ltd.
NVIDIA Corporation
Lifebit
BenevolentAI
Cambridge Cancer Genomics
Fabric Genomics Inc.
Verge Genomics
SOPHiA GENETICS
Freenome Holdings, Inc.
MolecularMatch Inc.
Data4Cure Inc.
PrecisionLife Ltd
Diploid
DNAnexus Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂